The p53-MDM2 Antagonist RG7388 Activates p53 and Induces a Predominantly Pro-Apoptotic Gene Expression Signature in Chronic Lymphocytic Leukemia

被引：1

作者：

Ciardullo, Carmela ^{[1
]}

Woodhouse, Laura ^{[2
]}

Aptullahoglu, Erhan ^{[1
]}

Wallis, Jonathan P. ^{[3
]}

Marr, Helen J. ^{[3
]}

Marshall, Scott R. ^{[4
]}

Bown, Nick ^{[5
]}

Willmore, Elaine ^{[1
]}

Lunec, John ^{[1
]}

机构：

[1] Newcastle Univ, Northern Inst Canc Res, Newcastle Upon Tyne, Tyne & Wear, England

[2] Newcastle Univ, Sch Med, Newcastle Upon Tyne, Tyne & Wear, England

[3] Freeman Rd Hosp, Dept Haematol, Newcastle Upon Tyne, Tyne & Wear, England

[4] City Hosp Sunderland NHS Trust, Dept Haematol, Sunderland, England

[5] Inst Med Genet, Northern Genet Serv, Newcastle Upon Tyne, Tyne & Wear, England

来源：

BLOOD | 2016年 / 128卷 / 22期

关键词：

D O I：

10.1182/blood.V128.22.893.893

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

893

引用

页数：6

共 50 条

[1] Non-genotoxic MDM2 inhibition selectively induces a pro-apoptotic p53 gene signature in chronic lymphocytic leukemia cells
Ciardullo, Carmela
Aptullahoglu, Erhan
Woodhouse, Laura
Lin, Wei-Yu
Wallis, Jonathan P.
Marr, Helen
Marshall, Scott
Bown, Nick
Willmore, Elaine
Lunec, John
HAEMATOLOGICA, 2019, 104 (12) : 2429 - 2442
[2] Discovery of RG7388, a Potent and Selective p53-MDM2 Inhibitor in Clinical Development
Ding, Qingjie
Zhang, Zhuming
Liu, Jin-Jun
Jiang, Nan
Zhang, Jing
Ross, Tina M.
Chu, Xin-Jie
Bartkovitz, David
Podlaski, Frank
Janson, Cheryl
Tovar, Christian
Filipovic, Zoran M.
Higgins, Brian
Glenn, Kelli
Packman, Kathryn
Vassilev, Lyubomir T.
Graves, Bradford
JOURNAL OF MEDICINAL CHEMISTRY, 2013, 56 (14) : 5979 - 5983
[3] Activation of p53 by the MDM2 antagonist RG7388 in CLL cells: analyses of ex vivo signaling, cell death and gene signature
Willmore, Elaine
Ciardullo, Carmela
Aptullahoglu, Erhan
Woodhouse, Laura
Wallis, Jonathan
Lunec, John
Marr, Helen
LEUKEMIA & LYMPHOMA, 2017, 58 : 187 - 188
[4] Discovery of Novel p53-MDM2 Inhibitor (RG7388)-Conjugated PlatinumIV Complexes as Potent Antitumor Agents
Liu, Wei
Ma, Yi
He, Youyou
Liu, Yanhong
Guo, Zhongjie
He, Jin
Han, Xiaodong
Hu, Yujiao
Li, Muqiong
Jiang, Ru
Wang, Shengzheng
JOURNAL OF MEDICINAL CHEMISTRY, 2024, 67 (11) : 9645 - 9661
[5] MDM2 inhibitor RG7388 potently inhibits tumors by activating p53 pathway in nasopharyngeal carcinoma
Fan, Xiaoqin
Wang, Yujie
Song, Jian
Wu, Hanwei
Yang, Ming
Lu, Lu
Weng, Xin
Liu, Lusha
Nie, Guohui
CANCER BIOLOGY & THERAPY, 2019, 20 (10) : 1328 - 1336
[6] Pre-clinical evaluation of the MDM2-p53 antagonist RG7388 alone and in combination with chemotherapy in neuroblastoma
Chen, Lindi
Rousseau, Raphael F.
Middleton, Steven A.
Nichols, Gwen L.
Newell, David R.
Lunec, John
Tweddle, Deborah A.
ONCOTARGET, 2015, 6 (12) : 10207 - 10221
[7] Preclinical Investigation of the p53MDM2 Antagonist Idasanutlin (RG7388) Demonstrates Significant Activity in High Risk Adult Acute Lymphoblastic Leukemia
Bell, Hayden L.
Singh, Mankaran
Blair, Helen J.
van Delft, Frederik W.
Moorman, Anthony V.
Lunec, John
Irving, Julie
BLOOD, 2020, 136
[8] p53 protein expression in chronic lymphocytic leukemia
Sellmann, Ludger
Carpinteiro, Alexander
Nueckel, Holger
Scholtysik, Rene
Siemer, Doerte
Klein-Hipass, Ludger
Kube, Dieter
Duerig, Jan
Duehrsen, Ulrich
Stanelle, Jens
Kueppers, Ralf
LEUKEMIA & LYMPHOMA, 2012, 53 (07) : 1282 - 1288
[9] The MDM2 small-molecule inhibitor RG7388 leads to potent tumor inhibition in p53 wild-type neuroblastoma
Lakoma, A.
Barbieri, E.
Agarwal, S.
Jackson, J.
Chen, Z.
Kim, Y.
McVay, M.
Shohet, J. M.
Kim, E. S.
CELL DEATH DISCOVERY, 2015, 1
[10] Protoporphyrin IX is a dual inhibitor of p53/MDM2 and p53/MDM4 interactions and induces apoptosis in B-cell chronic lymphocytic leukemia cells
Jiang, Liren
Malik, Natasha
Acedo, Pilar
Zawacka-Pankau, Joanna
CELL DEATH DISCOVERY, 2019, 5 (1)

← 1 2 3 4 5 →